Cystic Fibrosis. Cystic fibrosis with pulmonary manifestations
Conditions
Interventions
Intervention 1: Intervention group: Patients receive 10 ml of thyme oxymel syrup, including aqueous extract of thymus vulgaris, vinegar, and honey, divided into two parts in the morning and evening fo
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 16 Years
Inclusion criteria
Inclusion criteria: Patients with cystic fibrosis Age above 5 years Outpatients
Exclusion criteria
Exclusion criteria: Patients less than 5 years old Hospitalization for any reason during treatment History of allergy to thyme, vinegar or honey Taking systemic corticosteroids by the patient Occurrence of special medical conditions and not using the medicine by the patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in patients' clinical symptoms. Timepoint: At the beginning and 8 weeks after the drug intervention. Method of measurement: Cystic fibrosis quality of life questionnaire.;Changes in respiratory test results. Timepoint: At the beginning and 8 weeks after the drug intervention. Method of measurement: Spirometry.;Changes in respiratory test results. Timepoint: At the beginning and 8 weeks after the drug intervention. Method of measurement: IOS (Impedance Ocsillometry). | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in patients' quality of life. Timepoint: First and 8 weeks after drug intervention. Method of measurement: Cystic fibrosis quality of life questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Fatemeh Sajedi
Mashhad University of Medical Sciences
Outcome results
None listed